From: IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients
Patients | Number |
---|---|
MDS | 39 |
Gender | |
Male/Female | 18/21 |
Age (years), median (range): | 69 (27–89) |
WHO classification | |
RA/RARS/RCMD | 04/07/20 |
RAEB-1/RAEB-2 | 07/01 |
Cytogenetic riska | |
Very good/good | 01/32 |
Intermediate | 02 |
Poor/very poor | 01/01 |
No growth | 02 |